Bill > HR2107

This bill reauthorizes and amends the program of payments to children's hospitals that operate graduate medical education programs, extending funding through fiscal year 2030. The key provisions include extending financial support to children's hospitals, with annual appropriations of $124 million for general support and $261 million for specific purposes. Critically, the bill introduces a significant new restriction: children's hospitals will be ineligible for payments if they provide certain medical procedures and drugs to individuals under 18 years of age related to gender transition or affirmation. The bill specifically defines "specified procedures and drugs" as surgical interventions and hormone treatments aimed at changing an individual's body to not correspond to their sex at birth. The bill does provide exceptions for medically necessary treatments, such as addressing genetic disorders of sex development, correcting chromosomal or hormonal abnormalities, treating injuries or infections, or addressing imminent medical emergencies. The legislation defines "sex" based on reproductive potential, chromosomes, hormones, gonads, and external genitalia present at birth, and is set to take effect starting in fiscal year 2026.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/2107/all-info